Yoshinori Moriyama
Overview
Explore the profile of Yoshinori Moriyama including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
174
Citations
4810
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tano S, Kotani T, Ushida T, Matsuo S, Yoshihara M, Imai K, et al.
Hypertens Res
. 2024 Dec;
48(3):884-893.
PMID: 39663391
The growing recognition of the importance of interpregnancy weight management in reducing hypertensive disorders of pregnancy (HDP) underscores the importance of effective preventive strategies. However, developing effective systems remains a...
2.
Ibayashi Y, Hasuzawa N, Nomura S, Kabashima M, Nagayama A, Iwata S, et al.
PLoS One
. 2024 Dec;
19(12):e0312352.
PMID: 39652536
Brown adipose tissue (BAT) thermogenesis is pivotal for maintaining body temperature and energy balance. Mitochondrial morphology is dynamically controlled by a balance between fusion and fission, which is crucial for...
3.
Matsuo S, Moriyama Y, Ushida T, Imai K, Tano S, Miki R, et al.
J Obstet Gynaecol Res
. 2024 Sep;
50(11):2038-2045.
PMID: 39319776
Aim: Prenatal maternal depression is known to affect the neurodevelopment of offspring. This study aimed to investigate the profile of umbilical cord serum in mothers with major depressive disorder (MDD)....
4.
Miyashita T, Murakami K, Kikuchi E, Ofusa K, Mikami K, Endo K, et al.
Science
. 2023 Dec;
382(6677):eadf7429.
PMID: 38127757
During aversive olfactory conditioning, aversive shock information needs to be transmitted to the mushroom bodies (MBs) to associate with odor information. We report that aversive information is transmitted by ensheathing...
5.
Tano S, Kotani T, Ushida T, Yoshihara M, Imai K, Nakamura N, et al.
Diabetol Metab Syndr
. 2023 Jun;
15(1):123.
PMID: 37296464
Background: Recent evidence suggests increased glucose variability (GV) causes endothelial dysfunction, a central pathology of hypertensive disorders of pregnancy (HDP). We aimed to investigate the association between GV in early...
6.
Moriyama Y, Hasuzawa N, Nomura M
Front Pharmacol
. 2022 Dec;
13:1080189.
PMID: 36569286
Vesicular nucleotide transporter (VNUT), an active transporter for nucleotides in secretory vesicles, is responsible for the vesicular storage of ATP and plays an essential role in purinergic chemical transmission. Inhibition...
7.
Moriyama Y, Hasuzawa N, Nomura M
Purinergic Signal
. 2022 Dec;
20(2):93-98.
PMID: 36525101
Chromaffin granules are secretory granules present in adrenal medulla chromaffin cells. They contain high contents of catecholamines and nucleotides and have been regarded as a model system for the study...
8.
Ushida T, Kotani T, Baba J, Imai K, Moriyama Y, Nakano-Kobayashi T, et al.
Arch Gynecol Obstet
. 2022 Dec;
308(6):1755-1763.
PMID: 36502513
Purpose: Predicting individual risks for adverse outcomes in preterm infants is necessary for perinatal management and antenatal counseling for their parents. To evaluate whether a machine learning approach can improve...
9.
Tano S, Kotani T, Ushida T, Yoshihara M, Imai K, Nakano-Kobayashi T, et al.
Sci Rep
. 2022 Oct;
12(1):17502.
PMID: 36261685
Preterm birth (PTB) is a leading cause of neonatal morbidity and mortality. Although PTB is known to recur, interpregnancy preventive strategies for PTB have not been established to date. Annual...
10.
Yoshinobu S, Hasuzawa N, Nagayama A, Iwata S, Yasuda J, Tokubuchi R, et al.
Clin Ther
. 2022 Sep;
44(10):1418-1426.
PMID: 36117045
Purpose: The ileal bile acid transporter inhibitor elobixibat was recently approved in Japan for use in the treatment of patients with chronic constipation. Elobixibat has been associated with increased plasma...